Finally, whether P2RX7 directly modulates mitochondrial damage or clearance in response to tau has yet to be fully elucidated, and future studies using human-derived samples will be important to validate the relevance of the microglial response to tauopathy-associated BDEVs. The gene discussed is MAPT; the disease is tauopathy.